Browse resources

Topic: Immunization financing

Total results with these characteristics: 128

Page 4 of 6  
‹ prev.
1
2
3
4
5
6
next ›

Investing Together for a Healthy Future: The 2016-2020 GAVI Alliance Investment Opportunity

This report makes the case for the GAVI Alliance's call for an additional investment of US$7.5 billion to help immunize an additional 300 million children from 2016 to 2020. It includes GAVI's plan for increasing the proportion of children worldwide …

Author: GAVI Alliance

Published: 2014

IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening

This web page contains the rationale for and resources related to the introduction of inactivated polio vaccine (IPV), withdrawal of oral polio vaccine (OPV), and routine immunization strengthening. It provides five in-depth modules covering issues …

Author: World Health Organization

Is the Pneumococcal Vaccine Advance Market Commitment Motivating Innovation and Increasing Manufacturing Capacity? Some Preliminary Answers

This article, published in Vaccine, provides preliminary evidence on the potential outcome of the pneumococcal vaccine Advance Market Commitment, with a focus on its impact on innovation in emerging vaccine manufacturers in low-resource countries. …

Author: Plahte J

Published: 2012

Japanese Encephalitis Morbidity, Mortality, and Disability: Reduction and Control by 2015

This strategic plan, prepared by PATH from the contributions of 17 partner organizations, provides details on priority activities that must be sustained for continued momentum in Japanese encephalitis (JE) control, including improved …

Author: PATH, Armed Forces Research Institute of Medical Sciences, BIKEN, et al.

Published: 2009

Landscape Analysis of Routine Immunization in Nigeria: Identifying Barriers and Prioritizing Interventions

This white paper provides an analysis of supply-side constraints and demand-side determinants of routine immunization coverage in Nigeria. It emphasizes that tackling the basic barriers to routine immunization in Nigeria—cold chain, transport, …

Author: International Vaccine Access Center

Published: 2012

Making New Vaccines Affordable: A Comparison of Financing Processes Used to Develop and Deploy New Meningococcal and Pneumococcal Conjugate Vaccines

Two innovative mechanisms have been used to accelerate the development of low-price supply lines for conjugate vaccines. The Meningitis Vaccine Project is a so-called push mechanism that facilitated technology transfer to an Indian company to …

Author: Hargreaves JR, Greenwood B, Clift C, et al.

Published: 2011

Malaria Vaccine Decision-Making Framework

As the development of malaria vaccines accelerates, work is also underway on the policy front to pave the way for decisions on possible malaria vaccine use. Early planning is crucial to the successful adoption and introduction of a vaccine. To …

Author: PATH

Published: 2012

A New Approach to Planning for Immunization - WHO-UNICEF Guidelines for Developing a Comprehensive Multi-Year Plan (cMYP)

The Global Immunization Vision and Strategy (GIVS) for 2006 to 2015 provides a framework for policymakers and stakeholders to have a unified vision of immunization and a set of strategies from which countries can select those most suited to their …

Author: World Health Organization; United Nations Children's Fund

New Decade of Vaccines

In December 2010, global health leaders committed to making the next 10 years the Decade of Vaccines - to ensure discovery, development, and delivery of lifesaving vaccines globally, especially to the poorest countries. This special series of …

Author: Horton R, ed.

Published: 2011

Pneumococcal AMC

This section on the GAVI Alliance's website provides information about the pilot pneumococcal Advance Market Commitment (AMC), which is an innovative funding mechanism. It incentivizes vaccine makers to produce suitable and affordable vaccines for …

Author: GAVI Alliance

Potential Cost-Effectiveness of Vaccination for Rotavirus Gastroenteritis in Eight Latin American and Caribbean Countries

Investigators developed a model using epidemiological evidence, country-specific cost estimates, and vaccine efficacy data to estimate the cost-effectiveness of rotavirus vaccination and determined that it would reduce health care expenses and …

Author: Rheingans R, Constenla D, Antil L, Innis B, Breuer T

Published: 2007

The Problems and Promise of Vaccine Markets in Developing Countries

This article, published in Health Affairs, discusses a number of promising and innovative approaches that are being explored to increase the incentives and reduce the risks of investing in vaccines for developing countries. These approaches aim …

Author: Batson A

Published: 2005

Procurement and Pricing of New Vaccines for Developing Countries

Several vaccines that have come to market, including the rotavirus, pneumococcal conjugate, and human papillomavirus vaccines, have the potential to bring large public health benefits to developing countries. This eight-page policy brief explains …

Author: International AIDS Vaccine Initiative

Published: 2008

Progress in Cervical Cancer Prevention: The CCA Report Card

This report assesses global readiness to fight cervical cancer using new approaches and new technologies, especially in regions where the disease is a common killer. It underscores the urgent need for the global community to prioritize cervical …

Author: Cervical Cancer Action

Published: 2012

Projected Health and Economic Impact of Rotavirus Vaccination in GAVI-Eligible Countries: 2011–2030

This article, published in Vaccine, projects the cost-effectiveness and health impact of rotavirus vaccines in countries eligible for support from the GAVI Alliance. The authors used a decision-analytic model to project the health outcomes and …

Author: Atherly DE, Lewis KDC, Tate J, Parashar UD, Rheingans RD

Published: 2012

Projected Health Benefits and Costs of Pneumococcal and Rotavirus Vaccination in Uganda

The authors of this article, published in Vaccine, determined the impact and cost-effectiveness of pneumococcal and rotavirus vaccination programs among children younge than five years of age in Uganda from the public health system perspective. They …

Author: Tate JE, Kisakye A, Mugyenyi P, Kizza D, Odiit A, Braka F

Published: 2011

Projected Impact and Cost-Effectiveness of a Rotavirus Vaccination Program in India, 2008

The authors of this article, published in Clinical Infectious Diseases, aimed to determine the potential impact and cost-effectiveness of a national rotavirus vaccination program in India. They compared the national rotavirus disease and cost burden …

Author: Esposito DH, Tate JE, Kang G, Parashar UD

Published: 2011

ProVac Pneumococcal e-Learning Course

This online course is a practical tool designed to aid policy makers, national-level managers of immunization programs and other experts in making evidence-based decisions regarding the introduction of conjugate pneumococcal vaccines into national …

Author: Pan American Health Organization

ProVac Rotavirus e-Learning Course

This online course is a practical tool designed to aid health care administrators in making evidence-based decisions regarding rotavirus vaccine introduction into national immunization programs. The module provides training on topics ranging from …

Author: Pan American Health Organization

Public Finance of Rotavirus Vaccination in India and Ethiopia: An Extended Cost-Effectiveness Analysis

This article, published in Vaccine, reports on a study that evaluated the potential impact of a publicly funded national rotavirus vaccination program in India and Ethiopia on reducing deaths and household costs due to rotavirus disease. The authors …

Author: Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R

Published: 2013

Pull Mechanisms for Value-Added Technologies for Vaccines

Project Optimize, a collaboration between PATH and the World Health Organization, commissioned this white paper to examine the issues influencing vaccine producer willingness to advance, adopt, and commercialize value-added technologies for …

Author: PATH, World Health Organization

Published: 2009

R&D for Diarrhoeal Diseases

While preventive measures such as clean drinking water and sanitation can reduce the risk of infection from diarrheal diseases, research and development (R&D) of new tools is equally important, particularly for vaccines as they can prevent …

Author: Policy Cures

Published: 2013

Reduced Price on Rotavirus Vaccines: Enough to Facilitate Access Where Most Needed?

This article, published in the Bulletin of the World Health Organization, examines whether the reduced prices for rotavirus vaccine are affordable enough to facilitate access to the vaccine where it is most needed. The study points to the rotavirus …

Author: Madsen LB, Ustrup M, Fischer TK, Bygbjerg IC, Konradsen F

Published: 2012

Revised Procedure for WHO Prequalification of Vaccines

This web page provides an explanation and link to the revised procedure for assessing the acceptability of vaccines in order to verify that they meet the specifications of the relevant United Nations agency for procurement and that they are produced …

Author: World Health Organization

Published: 2013

RHO Cervical Cancer Library

This website is designed to provide easy access to science-based information for health program managers and decision-makers seeking to prevent cervical cancer in developing countries and low-resource settings. The wide range of materials appearing …

Author: PATH

Page 4 of 6  
‹ prev.
1
2
3
4
5
6
next ›